• Activity Title

    Start Activity


    Cardiovascular Safety Of Ketogenic Therapy

     

  • Statement of Need/Program Overview

    It is now well-established in the medical literature that medical ketogenic diets can be powerful treatments for chronic conditions like epilepsy, insulin resistance, type 2 diabetes, and obesity. As ketogenic therapy is being researched as a novel treatment for a number of other diseases that may be rooted in metabolic dysfunction – such as serious mental illness – it has become increasingly important to study and examine whether such therapy comes with serious risks. Many physicians and media outlets have raised concerns that ketogenic diets – which are high in fat – could be associated with an increased risk of cardiovascular complications like heart attack and stroke. This activity will explore the scientific and clinical evidence addressing these concerns, taking care to point out where the evidence is strong and where it is weak.

  • Target Audience

    This activity is designed for primary care and psychiatric physicians, cardiologists, endocrinologists, nurse practitioners and physician assistants as well as licensed mental health therapists and dieticians. All levels of experience are welcome.

  • Educational Objectives

    After completing this activity, the participant should be better able to:

    1. Recognize that ketogenic metabolic therapy is different from simply “eating keto.”
    2.  Explain how ketogenic therapy improves metabolic health, improving the vast majority of measurable cardiovascular risk factors.
    3.  Describe the scientific and clinical evidence demonstrating the ways in which the cardiovascular risks of eating low carb/high fat are often misrepresented and incorrectly portrayed in the scientific and press.
    4.  Recognize that data suggests concerns about elevated LDL-cholesterol and ketogenic therapy are relevant only to a minority of individuals.
    5. Incorporate acquired knowledge on the latest findings on ketogenic therapy for serious mental illness into current practice to better address the needs of their patients, and to optimize patient outcomes.

  • Faculty

    Bret Scher, MD
    Cardiologist 
    Medical Director, Baszucki Group and Metabolic Mind

    Matthew Budoff, MD
    Investigator, The Lindquist Institute
    Professor of Medicine, David Geffen School of Medicine at UCLA
    Program Director and Director of Cardiac CT, Division of Cardiology
    Harbor-UCLA Medical Center

  • European Accreditation Council for Continuing Medical Education (EACCME)

    EACCME Accreditation Statement

    The Cardiovascular Safety Of Ketogenic Therapy, made available and organized by Dane Garvin Ltd., is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) to provide the following CME activity for medical specialists. 

    Only those e-learning materials that are displayed on the UEMS-EACCME® website have formally been accredited.

    Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits TM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

  • EACCME Term Offering

    August 13, 2025 to August 25, 2027

     

    Information regarding the conversion of EACCME® credits
    Credit will be converted based on one (1) hour of participation equalling one credit for all activities. Physicians wishing to convert EACCME® credits to AMA PRA Category 1 Credit™ will be required to access the AMA website at https://edhub.ama-assn.org/pages/applications to obtain the necessary paperwork and instructions. Physicians and other health care professionals will be required to pay a processing fee to the AMA.

  • American Academy of Family Physicians (AAFP) Accreditation

    AAFP Accreditation Statement
    The AAFP has reviewed Cardiovascular Safety Of Ketogenic Therapy and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credit(s).

    Term of Approval is from 03/18/2026 to 03/18/2027. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Other Allied Healthcare Professional

    Participation Statement
    Dane Garvin Ltd. has awarded 1.0 Participation Credit(s) for qualified attendees in the enduring activity Cardiovascular Safety Of Ketogenic Therapy.

  •  

  • Educational Grant

    This activity is supported by an educational grant from Metabolic Mind which is a non-profit organization.

  • Copyright

    Copyright© Dane Garvin Ltd. All Rights Reserved. Permission for use granted to accreditation providers.

  • Web interface provided by Dane Garvin Ltd.

     

Contact Us